Browse by People
Number of items: 5.
Ferner, R.E.,
Thomas, M.,
Mercer, G.,
Williams, V.,
Leschziner, G.D.,
Afridi, S.K. and
Golding, J.F.
(2017)
Evaluation of quality of life in adults with neurofibromatosis 1 (NF1) using the Impact of NF1 on Quality Of Life (INF1-QOL) questionnaire.
Health and Quality of Life Outcomes, 15.
p. 34.
ISSN 1477-7525
Morris, K.A.,
Golding, J.F.,
Blesing, C.,
Evans, D.G.,
Ferner, R.E.,
Foweraker, K.,
Halliday, D.,
Jena, R.,
McBain, C.,
McCabe, M.G.,
Swampillai, A.,
Warner, N.,
Wilson, S.,
Parry, A. and
Afridi, S.
(2016)
Toxicity profile of bevacizumab in the UK Neurofibromatosis Type 2 cohort.
Journal of Neuro-oncology, 131.
pp. 117-124.
ISSN 0167-594X
Morris, K.A.,
Golding, J.F.,
Afridi, S.,
Blesing, C.,
Ferner, R.E.,
Halliday, D.,
Jena, R.,
Pretorius, P.M.,
Parry, A.,
Axon, P.R.,
Evans, D.G. and
McCabe, M.G.
(2016)
Bevacizumab in NF2-related vestibular schwannomas: a nationally coordinated approach to delivery and prospective evaluation.
Neuro-Oncology Practice, 3 (4).
pp. 281-289.
ISSN 2054-2577
Ferner, R.E.,
Shaw, A.,
Evans, D.G.,
McAleer, D.,
Halliday, D.,
Parry, A.,
Raymond F, L.,
Durie-Gair, J.,
Hanemann C, O.,
Hornigold, R.,
Axon, P.R. and
Golding, J.F.
(2014)
Longitudinal evaluation of quality of life in 288 patients with Neurofibromatosis 2.
Journal of Neurology, 26 (5).
pp. 936-969.
ISSN 0340-5354
Ferner, R.E.,
Golding, John F.,
Smith, M.,
Calonje, E.,
Jan, W.,
Sanjayanathan, V. and
O'Doherty, M.
(2008)
[18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study.
Annals of Oncology, 19 (2).
pp. 390-394.
ISSN 0923-7534
This list was generated on Sat Apr 21 23:25:42 2018 BST.